Prof. Dr. Şahika Zeynep Akı
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
Multiple Myeloma 16 publicationsSource: OpenAlex / PubMed MeSHView publications
- Graft vs Host Disease 6 publications
- Hodgkin Disease 5 publications
- Hepatitis B 4 publications
- Leukemia 4 publications
- Hepatic Veno-Occlusive Disease 4 publications
- Leukemia, Lymphocytic, Chronic, B-Cell 4 publications
- Leukemia, Myeloid, Acute 4 publications
- Pneumonia 3 publications
- Lymphoma 3 publications
- Lung Diseases 2 publications
- Liver Diseases 2 publications
- Lymphoma, Non-Hodgkin 2 publications
- Thrombocytopenia 2 publications
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyHaematologysaglik.gov.trFrom source
- InstitutionAnkara Etlik Şehir Hastanesisaglik.gov.trFrom source
- Area of workMultiple MyelomaExtracted from 16 publications · Model version —From source
- Publications136 publicationsORCID, Europe PMC, OpenAlexFrom source
- ORCID0000-0002-3068-5085ORCIDFrom source
- Last synchronised5 November 2026 07:23https://etliksehir.saglik.gov.tr/TR-864307/klinik-doktorlarimiz.html#sahika-zeynep-akisaglik.gov.tr
Scientific work
Publications on Multiple Myeloma
-
Endocrine Complications in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation: Prevalence and Risk Factors
Selcuk Medical Journal, 2026
DOI 10.30733/std.2026.01940 Open-access full textSource: ORCID
-
National Perspectives on Academic CAR-T Cell Therapy in Türkiye: A Report from the Turkish Society of Hematology’s Scientific Subcommittee on Cell and Gene Therapies (TSH-CGT SSC)
Turkish journal of haematology : official journal of Turkish Society of Haematology, 2026
DOI 10.4274/tjh.galenos.2026.55822 PMID 42233538 Open-access full textSource: Europe PMC
-
Comparative prognostic performance of ELN 2022 and ELN 2024 risk classifications in a Turkish cohort of acute myeloid leukemia patients receiving hypomethylating agents and BCL-2 inhibitors
Acta Medica, 2026
DOI 10.32552/actamedica.2026.1271 Open-access full textSource: OpenAlex
-
Are the Neutrophil-to-lymphocyte Ratio and Lymphocyte-to-monocyte Ratio Prognostic Markers in Elderly Patients with Diffuse Large B-cell Lymphoma?
Acta haematologica oncologica Turcica., 2026
DOI 10.4274/ahot.galenos.2026.2026-4-1 Open-access full textSource: OpenAlex
-
C-Reactive Protein-to-Albumin Ratio (CAR) as a Prognostic Biomarker in Newly Diagnosed Acute Myeloid Leukemia Treated with Intensive Induction Therapy: A Single-Center Retrospective Cohort Study
Hitit Medical Journal, 2026
DOI 10.52827/hititmedj.2012111 Open-access full textSource: OpenAlex
-
Thrombotic and hemorrhagic complications in NPM1-mutated AML: Association with APL-like immunophenotype and impact on early mortality
Journal of Thrombosis and Thrombolysis, 2026
DOI 10.1007/s11239-026-03410-4 PMID 42878784 Source: OpenAlex
-
Overview of Acute Myeloid Leukemia with TP53 Mutation: Single Center, Real-Life Data
Hitit Medical Journal, 2025
DOI 10.52827/hititmedj.1628279 Open-access full textSource: OpenAlex
-
Allojeneik Kök Hücre Nakli ve Kötü Graft Fonksiyonu
Turkiye Klinikleri Hematology - Special Topics, 2021
Source: OpenAlex
-
Intercontinental study on pre-engraftment and post-engraftment Gram-negative rods bacteremia in hematopoietic stem cell transplantation patients: Risk factors and association with mortality.
The Journal of infection, 2020
DOI 10.1016/j.jinf.2020.11.002 PMID 33186673 10 citations (Europe PMC) Source: ORCID
-
PB2336 PRIMARY AND SECOND GRAFT FAILURES IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: PRE-TRANSPLANT RECIPIENT / DONOR CYTOMEGALOVIRUS SEROSTATUS CAN HAVE AN EFFECT ON GRAFT FAILURE
HemaSphere, 2019
DOI 10.1097/01.hs9.0000567808.52587.8b Open-access full textSource: OpenAlex